3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
Usage & Storage Description BPC-157 (Body Protection Compound-157) is a synthetic 15 amino acid pentadecapeptide sequence derived from the human gastric protein BPC, identified by CAS number 137525-51-0
Show details CASRN: 68-19-9 Drug Levels and Effects Summary of Use during Lactation Vitamin B 12 is a normal component of human milk.[1] The recommended daily intake in lactating women is 2.8 mcg and for infants aged 6 months or less is 0.4 mcg.[2] Some authorities recommend 5.5 mcg per day during lactation.[3] Supplementation may be necessary to achieve these recommended daily intakes or to correct a known deficiency
Quality Documentation 99%+ purity HPLC and Mass Spectrometry verified BPC-157 500mcg + TB-500 500mcg per capsule Batch-specific COA included with every order USA tested and fulfilled Read the BPC-157 and TB-500 research overview For laboratory research purposes only
Disclaimer: These supplements are intended to support general health and are not intended to diagnose, treat, cure, or prevent any disease
No blinded assessment
